A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients.

Validire P, Fermé C, Brice P, Diviné M, Gabarre J, Bouabdallah K, Fitoussi O, Chaoui D, Pacquement H, Soussain C, Carde P, Salhi R, Zanni M, Decaudin D

Open source

DOI: 10.1097/cad.0b013e3282f46aec
Published: 2008 Mar
Container: Anti-cancer drugs
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/cad.0b013e3282f46aec,
  title = {A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients.},
  author = {Validire P and Fermé C and Brice P and Diviné M and Gabarre J and Bouabdallah K and Fitoussi O and Chaoui D and Pacquement H and Soussain C and Carde P and Salhi R and Zanni M and Decaudin D},
  year = {2008},
  journal = {Anti-cancer drugs},
  doi = {10.1097/cad.0b013e3282f46aec},
  url = {https://doi.org/10.1097/cad.0b013e3282f46aec}
}

RIS

TY  - JOUR
TI  - A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients.
AU  - Validire P
AU  - Fermé C
AU  - Brice P
AU  - Diviné M
AU  - Gabarre J
AU  - Bouabdallah K
AU  - Fitoussi O
AU  - Chaoui D
AU  - Pacquement H
AU  - Soussain C
AU  - Carde P
AU  - Salhi R
AU  - Zanni M
AU  - Decaudin D
PY  - 2008
JO  - Anti-cancer drugs
DO  - 10.1097/cad.0b013e3282f46aec
UR  - https://doi.org/10.1097/cad.0b013e3282f46aec
ER  -

APA

P, V., C, F., P, B., M, D., J, G., K, B., O, F., D, C., H, P., C, S., P, C., R, S., M, Z., & D, D. (2008). A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients.. Anti-cancer drugs. https://doi.org/10.1097/cad.0b013e3282f46aec

Source records

pubmed · retrieved 2026-09-26T18:18:52.070Z